Understanding risk factors for cognitive problems in people with coronary heart disease
Official title: Association Between Modifiable Risk Factors and Cognitive Function in Patients With Coronary Heart Disease
Run by Beijing Anzhen Hospital · NCT07657624 · Data updated 2026-11-12
In people with coronary heart disease, this study tests how metabolic factors and imaging features relate to cognitive impairment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2352 (estimated) |
| Sponsor | Beijing Anzhen Hospital Academic / other |
| Locations | 1 site (Beijing, China) |
| Status | Recruiting |
| Started | June 30, 2025 |
| Main results expected | May 1, 2031 |
| Study ends | May 1, 2031 |
| Registry record updated | July 15, 2026 |
| Trial ID | NCT07657624 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with confirmed coronary heart disease who can complete neuropsychological testing and metabolic/imaging assessments.
✕Probably not a fit
Patients not experiencing cognitive impairment or those unable to complete imaging or neuropsychological testing may have limited direct benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective observational study enrolling about 2,352 adults with coronary heart disease at Beijing Anzhen Hospital. Participants undergo comprehensive cognitive testing, metabolic labs, and multimodal imaging (CCTA, cardiac MRI) plus sleep, frailty, and psychological assessments. The main goal is to identify risk factors associated with cognitive impairment and to explore possible mechanisms linking heart disease to brain function. Findings may help with early identification and personalized approaches to prevent or mitigate cognitive decline in CHD patients.
Why it matters
Potential benefit: If successful, the study could improve early detection of cognitive impairment in CHD patients and inform personalized strategies to reduce risk.
How similar studies have gone: Prior research in cardiovascular and metabolic health has linked cognitive changes to metabolic and imaging markers, but large-scale prospective data in CHD populations are less common, making this relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥ 18 years 2. Diagnosis of coronary heart disease (meeting at least one of the following): * Coronary angiography or coronary CTA showing ≥50% stenosis in ≥1 major coronary artery; * Established diagnosis of coronary heart disease with prior medical, interventional, or surgical treatment; * Objective evidence of myocardial ischemia or typical clinical symptoms 3. Completion of standardized neuropsychological assessment during hospitalization 4. Completion of metabolic marker evaluation (fasting glucose, insulin, HbA1c, etc.) and agreement to undergo relevant imaging and functional assessments 5. Provision of signed written informed consent Exclusion Criteria: 1. Previously diagnosed dementia. 2. History of stroke, cerebral hemorrhage, or other central nervous system diseases known to cause cognitive impairment. 3. Severe psychiatric disorders (e.g., schizophrenia, bipolar disorder). 4. Pregnancy or breastfeeding.
Where it's running
-
Beijing Anzhen Hospital
Beijing, China, China Recruiting
Study contacts
- Study coordinator: Chenchen Tu, Chief Physician
- Email: tcc2033@163.com
- Phone: 15201648899
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
NMR-based Risk Test and Digital Health Support for midlife adults in Eloisa
This study tests whether an NMR metabolomics risk test can guide tailored digital health programs for midlife adults at risk of diabetes, heart disease, stroke, kidney disease, or fatty liver.
-
Immediate vs progressive standing dual-task training for older adults with mild to moderate cognitive impairment
This study tests whether starting with immediate standing dual-task training is better or worse than progressively increasing the difficulty for older adults with mild to moderate cognitive impairment.
-
Prospective cardiac surgery cohort to improve perioperative care
A multi-center study will test a large, forward-looking database of adults undergoing heart surgery to better understand what affects short- and long-term outcomes.
-
Mazdutide and coronary plaque in people with coronary artery disease and overweight or obesity
This study tests whether mazdutide can slow or reduce coronary plaque build-up in adults with coronary artery disease who are overweight or obese.
-
Yiyang Huoluo Decoction for coronary heart disease with atherosclerosis in older adults
This study will test whether adding the Yiyang Huoluo herbal decoction to standard heart care helps people aged 50–75 with coronary heart disease and atherosclerosis.
-
Glycocalyx and oxidative stress in blood vessel lining during coronary bypass surgery
This project will see if changes in the endothelial glycocalyx and oxidative stress markers relate to microvascular function and outcomes in adults having elective coronary artery bypass grafting.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.